Capital Research Global Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.78B | Buy |
27,127,533
+1,820,462
| +7% | +$255M | 0.59% | 37 |
|
|
2025
Q4 | $3.11B | Sell |
25,307,071
-4,706,975
| -16% | -$572M | 0.57% | 37 |
|
|
2025
Q3 | $3.33B | Sell |
30,014,046
-1,083,633
| -3% | -$123M | 0.63% | 34 |
|
|
2025
Q2 | $3.45B | Sell |
31,097,679
-23,512,691
| -43% | -$2.5B | 0.69% | 31 |
|
|
2025
Q1 | $6.12B | Sell |
54,610,370
-3,335,858
| -6% | -$344M | 1.33% | 18 |
|
|
2024
Q4 | $5.35B | Sell |
57,946,228
-3,853,443
| -6% | -$347M | 1.1% | 22 |
|
|
2024
Q3 | $5.18B | Buy |
61,799,671
+1,371,957
| +2% | +$105M | 1.08% | 22 |
|
|
2024
Q2 | $4.15B | Sell |
60,427,714
-818,652
| -1% | -$54.6M | 0.91% | 24 |
|
|
2024
Q1 | $4.49B | Buy |
61,246,366
+1,589,240
| +3% | +$122M | 1.02% | 25 |
|
|
2023
Q4 | $4.83B | Buy |
59,657,126
+1,743,418
| +3% | +$136M | 1.19% | 17 |
|
|
2023
Q3 | $4.34B | Buy |
57,913,708
+14,039
| +0% | +$1.08M | 1.2% | 20 |
|
|
2023
Q2 | $4.46B | Sell |
57,899,669
-378,438
| -0.6% | -$30.2M | 1.2% | 15 |
|
|
2023
Q1 | $4.84B | Buy |
58,278,107
+3,675,155
| +7% | +$304M | 1.38% | 13 |
|
|
2022
Q4 | $4.69B | Buy |
54,602,952
+727,482
| +1% | +$57.6M | 1.42% | 13 |
|
|
2022
Q3 | $3.32B | Sell |
53,875,470
-2,100,510
| -4% | -$132M | 1.09% | 19 |
|
|
2022
Q2 | $3.46B | Buy |
55,975,980
+24,601
| +0% | +$1.52M | 1.08% | 20 |
|
|
2022
Q1 | $3.33B | Sell |
55,951,379
-51,205,602
| -48% | -$3.27B | 0.82% | 28 |
|
|
2021
Q4 | $7.78B | Sell |
107,156,981
-7,391,127
| -6% | -$509M | 1.72% | 11 |
|
|
2021
Q3 | $8B | Sell |
114,548,108
-2,123,447
| -2% | -$149M | 1.87% | 10 |
|
|
2021
Q2 | $8.03B | Sell |
116,671,555
-5,934,783
| -5% | -$396M | 1.87% | 8 |
|
|
2021
Q1 | $7.92B | Buy |
122,606,338
+933,939
| +0.8% | +$60.2M | 1.94% | 9 |
|
|
2020
Q4 | $7.09B | Buy |
121,672,399
+4,559,152
| +4% | +$275M | 1.84% | 9 |
|
|
2020
Q3 | $7.4B | Sell |
117,113,247
-8,243,635
| -7% | -$572M | 2.22% | 8 |
|
|
2020
Q2 | $9.64B | Buy |
125,356,882
+29,374,563
| +31% | +$2.25B | 3.05% | 6 |
|
|
2020
Q1 | $7.18B | Buy |
95,982,319
+10,849,434
| +13% | +$750M | 2.82% | 6 |
|
|
2019
Q4 | $5.53B | Buy |
85,132,885
+8,343,863
| +11% | +$543M | 1.66% | 11 |
|
|
2019
Q3 | $4.87B | Sell |
76,789,022
-4,959,665
| -6% | -$324M | 1.6% | 10 |
|
|
2019
Q2 | $5.52B | Buy |
81,748,687
+3,562,752
| +5% | +$234M | 1.75% | 8 |
|
|
2019
Q1 | $5.08B | Buy |
78,185,935
+5,637,146
| +8% | +$375M | 1.61% | 13 |
|
|
2018
Q4 | $4.54B | Buy |
72,548,789
+2,693,821
| +4% | +$188M | 1.58% | 14 |
|
|
2018
Q3 | $5.39B | Buy |
69,854,968
+12,818,301
| +22% | +$968M | 1.57% | 12 |
|
|
2018
Q2 | $4.04B | Buy |
57,036,667
+14,093,328
| +33% | +$995M | 1.1% | 22 |
|
|
2018
Q1 | $3.24B | Buy |
42,943,339
+10,620,098
| +33% | +$844M | 0.92% | 27 |
|
|
2017
Q4 | $2.32B | Buy |
32,323,241
+10,454,610
| +48% | +$794M | 0.68% | 38 |
|
|
2017
Q3 | $1.77B | Buy |
21,868,631
+3,568,873
| +20% | +$273M | 0.53% | 51 |
|
|
2017
Q2 | $1.3B | Sell |
18,299,758
-3,174,773
| -15% | -$211M | 0.41% | 65 |
|
|
2017
Q1 | $1.46B | Sell |
21,474,531
-3,298,010
| -13% | -$232M | 0.46% | 59 |
|
|
2016
Q4 | $1.77B | Sell |
24,772,541
-3,113,989
| -11% | -$231M | 0.58% | 48 |
|
|
2016
Q3 | $2.21B | Buy |
27,886,530
+2,474,271
| +10% | +$201M | 0.73% | 37 |
|
|
2016
Q2 | $2.12B | Sell |
25,412,259
-5,703,568
| -18% | -$506M | 0.72% | 36 |
|
|
2016
Q1 | $2.86B | Sell |
31,115,827
-22,012,580
| -41% | -$1.99B | 0.99% | 25 |
|
|
2015
Q4 | $5.38B | Sell |
53,128,407
-16,873,389
| -24% | -$1.76B | 1.84% | 7 |
|
|
2015
Q3 | $6.87B | Sell |
70,001,796
-29,989,724
| -30% | -$3.33B | 2.46% | 4 |
|
|
2015
Q2 | $11.7B | Sell |
99,991,520
-977,740
| -1% | -$107M | 3.85% | 2 |
|
|
2015
Q1 | $9.91B | Buy |
100,969,260
+3,111,900
| +3% | +$316M | 3.39% | 2 |
|
|
2014
Q4 | $9.22B | Sell |
97,857,360
-24,418,524
| -20% | -$2.53B | 3.13% | 2 |
|
|
2014
Q3 | $13B | Sell |
122,275,884
-15,504,770
| -11% | -$1.52B | 4.51% | 2 |
|
|
2014
Q2 | $11.4B | Buy |
137,780,654
+14,889,230
| +12% | +$1.16B | 3.99% | 1 |
|
|
2014
Q1 | $8.71B | Sell |
122,891,424
-13,175,846
| -10% | -$1.03B | 3.15% | 2 |
|
|
2013
Q4 | $10.2B | Sell |
136,067,270
-17,621,556
| -11% | -$1.23B | 3.79% | 1 |
|
|
2013
Q3 | $9.66B | Sell |
153,688,826
-2,980,000
| -2% | -$178M | 3.81% | 1 |
|
|
2013
Q2 | $8.02B | Buy |
+156,668,826
| New | +$8.17B | 3.41% | 2 |
|
Other funds holding GILD
VCM
VPM
Capital Research Global Investors's GILD Position: Q1 2026 in Review
Capital Research Global Investors increased its Gilead Sciences (GILD) stake by 7.2% in Q1 2026, buying an estimated $255M and bringing the position to 27,127,533 shares worth $3.78B. The position accounts for 0.59% of the portfolio, ranked #37.
Capital Research Global Investors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $13B in Q3 2014. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Capital Research Global Investors held 27,127,533 shares of Gilead Sciences worth $3.78B as of Q1 2026.
- Capital Research Global Investors bought 1,820,462 Gilead Sciences shares in Q1 2026, an estimated $255M.
- Gilead Sciences made up 0.59% of Capital Research Global Investors's portfolio in Q1 2026, its #37 holding.
- Capital Research Global Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Capital Research Global Investors's Gilead Sciences position peaked at $13B in Q3 2014.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.